SCHEMBL143014

SCHEMBL143014

CCCCN1C(=O)CC(=O)NC1=S

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
ALDH1A1 P00352 4/20 0.48
L3MBTL1 Q9Y468 4/20 0.48
BLM P54132 2/20 0.48
MAPT P10636 3/20 0.46
KDM4E B2RXH2 2/20 0.46
POLB P06746 2/20 0.46
THRB P10828 2/20 0.46
HPGD P15428 2/20 0.46
ALOX12 P18054 2/20 0.46
APEX1 P27695 2/20 0.46
RECQL P46063 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
USP2 O75604 1/20 0.46
CNR1 P21554 3/20 0.43
FAAH O00519 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
MGLL Q99685 1/20 0.37
CYP19A1 P11511 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20151661 0.89 MEN1 (0.53) MEN1KMT2AALDH1A1L3MBTL1BLM
SCHEMBL2161839 0.84 MAPT (0.49) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL12851529 0.82 MEN1 (0.56) MEN1KMT2AALDH1A1L3MBTL1BLM
Hydrochloric Acid SCHEMBL7548680 0.81 MAPT (0.46) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL6332925 0.79 MEN1 (0.56) MEN1KMT2AALDH1A1L3MBTL1BLM
SCHEMBL28151841 0.79 MAPT (0.47) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL28750233 0.77 MGLL (0.47) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL9885893 0.77 MGLL (0.47) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL145408 0.76 KDM4E (0.46) MEN1KMT2AALDH1A1L3MBTL1BLM
SCHEMBL23068192 0.75 KMT2A (0.69) MEN1KMT2AALDH1A1L3MBTL1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2012-03-08 US disclosed
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use INCENP, CYBA, ADCY5 MEN1 4480/4885KMT2A 3041/4885ALDH1A1 371/4885
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use INCENP, CYBA, PAICS MEN1 4473/4885KMT2A 2961/4885ALDH1A1 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.